Fastclav 250 Tablet is a combination antibiotic containing Cefuroxime 250mg and Clavulanic Acid 62.5mg, designed to treat a variety of bacterial infections effectively. Cefuroxime, a second-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing bacterial enzymes from breaking down Cefuroxime, thereby enhancing its efficacy against beta-lactamase producing resistant strains. This synergistic combination makes Fastclav 250 effective against respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain types of sinusitis and otitis media. It is typically prescribed when infections are caused by bacteria resistant to other antibiotics or when a broad-spectrum antibiotic is needed. Fastclav 250 should be taken as directed by a healthcare professional, usually with food to improve absorption and reduce gastrointestinal discomfort. Patients should complete the full course of therapy to prevent the development of resistance. Common side effects may include mild gastrointestinal disturbances such as nausea, diarrhea, or abdominal pain. It is important to inform the doctor of any allergies to cephalosporins, penicillins, or other medications before starting treatment with Fastclav 250 Tablet.